Alkermes plc (ALKS)

NASDAQ: ALKS · Real-Time Price · USD

30.10

-0.63 (-2.05%)

At close: Feb 27, 2026, 4:00 PM EST

30.30

+0.20 (0.66%)

After-hours: Feb 27, 2026, 4:57 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Developing, Manufacturing and Commercializing Medicines	1.48B	1.56B	1.66B	1.11B	1.17B
Developing, Manufacturing and Commercializing Medicines Growth	-5.25%	-6.36%	49.61%	-5.28%	13.00%
Total	1.48B	1.56B	1.66B	1.11B	1.17B
Total Growth	-5.25%	-6.36%	49.61%	-5.28%	13.00%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States (U.S.)	1.37B	1.41B	1.49B	931.99M	984.24M
United States (U.S.) Growth	-2.65%	-5.48%	60.08%	-5.31%	17.31%
Ireland	754.00K	1.29M	1.18M	1.83M	2.18M
Ireland Growth	-41.73%	9.75%	-35.54%	-15.91%	-32.73%
Rest of World	102.36M	146.18M	170.29M	177.98M	187.34M
Rest of World Growth	-29.98%	-14.16%	-4.32%	-5.00%	-4.67%
Total	1.48B	1.56B	1.66B	1.11B	1.17B
Total Growth	-5.25%	-6.36%	49.61%	-5.28%	13.00%

Source: S&P Global Market Intelligence.